OxyContin’s Academic Marketing: The Studies That Fueled the Opioid Crisis

Purdue Pharmaceuticals used to cite three major studies to argue that in prescribing OxyContin, addiction-risk was not significant. The most influential of those studies did not even mention OxyContin, because it was completed twenty-five years before OxyContin was sold. After more than a decade, the company had to admit that “data are not available to establish the true incidence of addiction.”

Read more